Mgc Diagnostics Corp (MGCD) 6.55 $MGCD MGC Diagnostics

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2016 at 4:08 AM

Mgc Diagnostics Corp (MGCD) 6.55 $MGCD

MGC Diagnostics Corporation Announces Early Repayment of Debt
PR Newswire - Tue Jun 14, 3:01PM CDT
MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today announced that it has paid off the remaining $2.5 million balance of its five-year, $4.0 million term loan and has terminated its revolving credit facility with BMO Harris Bank. The Company also announced it has resolved pending litigation with NeuroVirtual regarding a disputed distribution agreement.
MGCD: 6.55 (+0.10)

MGC Diagnostics Corporation Reports Fiscal 2016 Second Quarter Results
PR Newswire - Wed Jun 01, 3:01PM CDT
MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the second quarter ended April 30, 2016.
MGCD: 6.55 (+0.10)

MGC Diagnostics Corporation to Report Second Quarter Fiscal Year 2016 Financial Results on Wednesday, June 1, 2016
PR Newswire - Tue May 24, 7:00AM CDT
MGC Diagnostics Corporation (NasdaqCM: MGCD), a global medical technology company, today scheduled a conference call to discuss its financial results for the second quarter fiscal year 2016, ended April 30, 2016. The call will be at 4:30 p.m. ET on Wednesday, June 1, 2016. The Company will report financial results for the second quarter fiscal year 2016 after the markets close on Wednesday, June 1, 2016.
MGCD: 6.55 (+0.10)

MGC Diagnostics Corporation Reports Fiscal 2016 First Quarter Results
PR Newswire - Tue Mar 08, 3:01PM CST
MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the first quarter ended January 31, 2016.
MGCD: 6.55 (+0.10)

MGC Diagnostics Corporation Reports Fiscal Year 2015 Financial Results
PR Newswire - Wed Jan 06, 3:01PM CST
MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the fourth quarter and the fiscal year 2015, ended October 31, 2015.
MGCD: 6.55 (+0.10)

MGC Diagnostics Corporation to Report Fourth Quarter and Fiscal Year 2015 Financial Results on Wednesday, January 6, 2016
PR Newswire - Thu Dec 17, 7:00AM CST
MGC Diagnostics Corporation (NasdaqCM: MGCD), a global medical technology company, today scheduled a conference call to discuss its financial results for the fourth quarter and fiscal year 2015, ended October 31, 2015. The call will be at 4:30 p.m. ET on Wednesday, January 6, 2016. The Company will report financial results for the fourth quarter and fiscal year 2015 after the markets close on Wednesday, January 6, 2016.
MGCD: 6.55 (+0.10)

Metabolic Testing Solutions - Global Strategic Business Report - Key Players are AEI Technologies, Bodystat, CareFusion, CORTEX Biophysik GmbH & COSMED
M2 - Fri Dec 04, 4:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/klmhsw/metabolic_testing) has announced the addition of the "Metabolic Testing Solutions - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Metabolic Testing Solutions in US$ Thousand by the following Product Segments: ECGs/EKGs, Metabolic Carts, CPET Systems, and Others. The market is also analyzed by the following Technologies: VO2 Max Analysis, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 91 companies including many key and niche players such as - - AEI Technologies, Inc. - Bodystat Limited - CareFusion Corporation - CORTEX Biophysik GmbH - COSMED Key Topics Covered: 1. OUTLOOK 2. INDUSTRY OVERVIEW 3. PRODUCT OVERVIEW 4. PRODUCT INNOVATIONS/INTRODUCTIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS - AEI Technologies, Inc. (US) - Bodystat Limited (UK) - CareFusion Corporation (US) - CORTEX Biophysik GmbH (Germany) - COSMED (Italy) - GE Healthcare (UK) - Geratherm Medical AG (Germany) - Hologic, Inc. (US) - InBody Co., Ltd. (South Korea) - Iworx Systems, Inc. (US) - Jawon Medical Co. Ltd. (South Korea) - KORR Medical Technologies, Inc. (US) - Laica SpA (Italy) - MGC Diagnostics Corporation (US) - Microlife Medical Home Solutions, Inc. (US) - Mindray Medical International Limited (China) - Mortara Instrument, Inc. (US) - Nihon Kohden Corporation (Japan) - Noraxon U.S.A., Inc. (US) - Omron Healthcare, Inc. (US) - Parvo Medics (US) - Philips Healthcare (Netherlands) - RJL Systems, Inc. (US) - Schiller AG (Switzerland) - seca GmbH & Co. KG. (Germany) - Spacelabs Healthcare, Inc. (US) - Tanita Corporation (Japan) - Welch Allyn, Inc. (US) 7. GLOBAL MARKET PERSPECTIVE For more information visit http://www.researchandmarkets.com/research/kl...ic_testing
CFN: 59.91 (-0.06), MGCD: 6.55 (+0.10), MR: 27.94 (+0.07), HOLX: 35.93 (+0.43)

MGC Diagnostics Corporation Enters The Japanese Market By Establishing Partnership With Pacific-Medico
PR Newswire - Tue Nov 10, 7:00AM CST
MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology leader, today announced it has signed a multi-year partnership agreement with Pacific-Medico CO., LTD., Tokyo, Japan, to exclusively market MGC Diagnostics' CCM Express indirect calorimeter system in Japan.
MGCD: 6.55 (+0.10)

MGC Diagnostics Names Frederic Gavage Managing Director of Medisoft S.A.
PR Newswire - Mon Nov 02, 7:00AM CST
MGC Diagnostics (NASDAQ: MGCD), a global medical technology company, announced today that Frederic Gavage has been named Managing Director of MediSoft S.A., a wholly-owned subsidiary of MGC Diagnostics, effective immediately. Mr. Gavage will be responsible for the general management of MediSoft and will play a key role in the implementation of the Company's corporate strategy.
MGCD: 6.55 (+0.10)

MGC Diagnostics Corporation Reports Fiscal 2015 Third Quarter Results
PR Newswire - Thu Sep 10, 3:01PM CDT
MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today reported financial results for the third quarter ended July 31, 2015.
MGCD: 6.55 (+0.10)

MGC Diagnostics Corporation to Report Second Quarter Fiscal 2015 Financial Results on Tuesday, June 2, 2015
PR Newswire - Tue May 26, 7:00AM CDT
MGC Diagnostics Corporation (NasdaqCM: MGCD), a global medical technology company, today scheduled a conference call to discuss its financial results for the second quarter of fiscal 2015, ended April 30, 2015. The call will be at 4:30 p.m. ET on Tuesday, June 2, 2015. The Company will report financial results for the second quarter of fiscal 2015 at the close of the markets on Tuesday, June 2, 2015.
MGCD: 6.55 (+0.10)

MGC Diagnostics Corporation Announces Newly Repackaged Ultima Series(TM)
PR Newswire - Wed May 13, 7:00AM CDT
MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology leader, announced today the release of its latest design of the Ultima Series TM cardiorespiratory diagnostic system, capable of performing both pulmonary function and metabolic testing in a single, modular, upgradeable platform, utilizing the latest technology. The system will be featured at the upcoming American Thoracic Society Meeting along with the full MGC Diagnostics Medical Graphics product line. Todd M. Austin, CEO of MGC Diagnostics, commented "This generation of MGC Diagnostic's Ultima Series TM, designed with both the patient and operator in mind, allows for maximum flexibility and operational efficiency, making it even easier to deliver cardiorespiratory diagnostic patient care with our intuitive, easy-to-use technology."
MGCD: 6.55 (+0.10)

Nasdaq stocks posting largest volume decreases
AP - Tue Apr 28, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest volume decliners on Nasdaq at the close of trading:
TSBK: 15.23 (+0.32), OPOF: 19.39 (-0.01), QADB: 17.80 (+0.60), ALOT: 15.80 (+0.27), HWBK: 13.70 (-0.03), WEBK: 20.25 (unch), QADA: 19.65 (+0.45), FCCO: 13.96 (-0.09), CHMG: 30.08 (+0.61), MGCD: 6.55 (+0.10), IKNX: 10.61 (+0.15)

Metabolic Testing Market by Product, by Application, by Technology, by End User - Global Forecast to 2019
M2 - Tue Mar 31, 5:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ncxgh5/metabolic_testing) has announced the addition of the "Metabolic Testing Market by Product (CPET, Body Composition Analysis, ECG, Portable System), by Application (Critical Care, Lifestyle Diseases), by Technology (REE, Body Composition Analysis), by End User (Gym, Sports, Hospital) - Global Forecast to 2019 " report to their offering. The global metabolic testing market is expected to reach $475.75 million by 2019 from $332.78 million in 2014, at a CAGR of 7.41% during the forecast period of 2014 to 2019. Metabolic testing equipment estimate the metabolic potential of an individual to determine their health and wellness. Metabolic testing equipment and software assist physicians and exercise physiologists to identify the risks of lifestyle disorders at an early stage and aid in the critical care of ICU patients. These equipments are also utilized in human performance testing for athletes and for commercial weight management programs. The lifestyle diseases segment accounted for the largest application segment of the metabolic testing market in 2014. In this report, the global metabolic testing market is segmented on the basis of products, technologies, applications, end users, and regions. The product segments of the market included in the report are CPET systems, metabolic carts, ECGs and EKGs, body composition analyzers, and software. The technology segments of the market included in the report are VO2 max analysis, RMR analysis, and body composition analysis. The application segments of the market included in the report are lifestyle diseases, critical care, human performance testing, dysmetabolic syndrome X, metabolic disorders, and other applications. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Metabolic Testing Market, By Product 8 Metabolic Testing Market, By Application 9 Metabolic Testing Market, By Technology 10 Metabolic Testing Market, By End User 11 Geographic Analysis 12 Competitive Landscape 13 Company Profiles - AEI Technologies, Inc. - Carefusion Corporation - Cortex Biophysik GMBH - Cosmed - General Electric Company - Geratherm Medical AG - Korr Medical Technologies, Inc. - MGC Diagnostics Corporation - Microlife Medical Home Solutions, Inc. - OSI Systems, Inc. - Parvo Medics For more information visit http://www.researchandmarkets.com/research/nc...ic_testing
GE: 32.20 (+0.38), MGCD: 6.55 (+0.10), OSIS: 57.69 (+1.77)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ROKFORM Unleashes Rangefinder 18X with Bold Features

Strong Magnets and Smarter Tracking: A Golfer's Companion Forget about the agony of misplacing that pricey bit of tech you thought was secure on your golf cart. ROKFORM's new Rangefinder 18X promises to stick around with its bold tech debut. We're talking a magnet on steroids here—up to three times stronger than the competition. If your last purchase slipped on a bumpy...

Grid Hurdles Stalling Industrial Heat's Future Growth

The Grid's the New Ball and Chain Now that we're done fiddling with tech, let's talk grid. The industrial players itching to switch to electric heat have found a new villain: the grid. You'd think with resistance heating, electric boilers, electric arc furnaces, and the whole shebang ready to roll, it’d be a smooth ride. But nope, the bottleneck's the bloodstream...

MLS Org's Sue Compass to Safeguard Fair Listing Access

Real Estate Clash: MLS vs. Compass Imagine flipping on the TV to see a legal showdown brewing in the real estate world — you've got six heavy-hitter MLSs facing off against Compass, Inc. Yeah, we're talking a legal slugfest here, folks, as these MLSs rally to keep the playing field level for over 120,000 agents across the country. They're not messing around, bringing a...

Sheep Meet Solar: Maryland's Agrivoltaics Unfurled

Who would have thought sheep could be power players in Maryland's clean energy scene? But here we are, staring at a field in Cooksville where eighty sheep graze under the watchful gaze of solar panels. It’s not your everyday scene, but it’s a sign of the times when energy meets agriculture head-on. The Unlikely Marriage of Solar and Sheep What we’re looking at is a...

LEDC and Crosson Lead the Charge in Community Finance

Recognizing Game-Changers in Community Development Finance In the financial landscape, it's not always about the big tickers and glitzy IPOs. Sometimes, it's the intrepid ground-level players who make the real difference. That's exactly what happened when the Opportunity Finance Network (OFN) held its 42nd annual conference in New Orleans, honoring standouts in the realm...

College Athletics Needs a New Business Revolution

Wake Up Call for College Athletics Here's a heads-up—college sports aren't just about cheering fans and game-day jerseys anymore. It's high time universities start thinking of athletics as businesses, blending the thrill of game day with the realities of financial statements. Michael Schreiber rang this bell loud and clear on the 'Disruption Interruption' podcast,...

China's Sewing Machine Exports: Global Expansion Surge

China's Position as a Sewing Machine Powerhouse It seems like the global sewing machine market is having a bit of a renaissance, and China's sitting pretty right at the center. You see, places like Taizhou in Zhejiang Province aren’t just pushing out volume—they're slamming market demand with innovation and precision. Once known primarily as the manufacturing hub,...

Frost & Sullivan Boosts China Insight with LeadLeo

Navigating China's Complex Market Landscape You've got to understand, the stakes in China are like a high-wire act—mystifying and risky, yet bountiful if you play your cards right. Frost & Sullivan's latest maneuver into China's business intel scene is basically the lifeline for navigating this increasingly convoluted market. With China surging ahead in AI, biotech, and...

LifeWave's Bold New Path in Human Performance

Redefining the Everyday Athlete Not every day you see a wellness company talking about 'performance' in the broader human sense. Not just for the pros or those beating personal records but for anyone looking to lift the quality of their daily grind. That's the new line LifeWave's drawing in the sand with their spiffy 'Human Performance Technology.' They're looking to...

Monigle's 7 Transform Awards: Building Human Connections

Award-Winning Branding with Heart Alright, let’s dig into Monigle's world—a place where branding isn't just a static logo slapped on anything that moves but is instead about creating alive, breathing experiences that genuinely connect with people. They didn't just turn heads at the Transform Awards North America, they're the ones with jaws dropping, folks. Seven...